Grafts in myringoplasty: Utilizing a silk fibroin scaffold as a novel device

Expert Review of Medical Devices

Volumn 6, Issue 6, 2009, Pages 653-664

  Levin, Brett ^a   Rajkhowa, Rangam ^b   Redmond, Sharon Leanne ^a   Atlas, Marcus David ^a,c,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c ST JOHN OF GOD HOSPITAL   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Biomaterial; Fibroin; Graft; Myringoplasty; Perforation; Silk; Tissue engineering; Tympanic membrane

Indexed keywords

ANTIBIOTIC AGENT; BIOMATERIAL; SILK FIBROIN; TISSUE SCAFFOLD;

ALLOGRAFT; AUTOGRAFT; BIOCOMPATIBILITY; BIODEGRADATION; BIOMECHANICS; CARTILAGE GRAFT; EARDRUM PERFORATION; HEAD AND NECK SURGERY; HEARING ACUITY; HEARING LOSS; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; MORBIDITY; MYRINGOPLASTY; NONHUMAN; OTITIS MEDIA; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; SURGICAL APPROACH; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TISSUE GRAFT; WOUND HEALING;

ANIMALS; BIOCOMPATIBLE MATERIALS; EQUIPMENT AND SUPPLIES; EQUIPMENT DESIGN; FIBROINS; HUMANS; KERATINOCYTES; MYRINGOPLASTY; SILK; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TYMPANIC MEMBRANE PERFORATION;

EID: 73549119697     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.09.47     Document Type: Review

References (121)

1. Farrior JB. Incisions in tympanoplasty: anatomic considerations and indications. Laryngoscope 93(1), 75-86 (1983).
2. Darrow DH, Dash N, Derkay CS. Otitis media: concepts and controversies. Curr. Opin. Otolaryngol. Head Neck Surg. 11(6), 416-423 (2003).
3. Freid VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat. 13(137), 1-23 (1998).
4. Nash DR, Harman J, Wald ER et al. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections. Arch. Pediatr. Adolesc. Med. 156(11), 1114-1119 (2002).
5. Bluestone CD. Epidemiology and pathogenesis of chronic suppurative otitis media: implications for prevention and treatment. Int. J. Pediatr. Otorhinolaryngol. 42(3), 207-223 (1998).
6. Verhoeff M, van der Veen EL, Rovers MM et al. Chronic suppurative otitis media: a review. Int. J. Pediatr. Otorhinolaryngol. 70(1), 1-12 (2006).
7. Nittrouer S, Burton LT, Nittrouer S, Burton LT. The role of early language experience in the development of speech perception and phonological processing abilities: evidence from 5-year-olds with histories of otitis media with effusion and low socioeconomic status. J. Comm. Disorders 38(1), 29-63 (2005).
8. Osma U, Cureoglu S, Hosoglu S. The complications of chronic otitis media: report of 93 cases. J. Laryngol. Otol. 114(2), 97-100 (2000).
9. Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J. Laryngol. Otol. 107(11), 999-1004 (1993).
10. Trimis G, Mostrou G, Lourida A, Prodromou F, Syriopoulou V, Theodoridou M. Petrositis and cerebellar abscess complicating chronic otitis media. J. Paediatr. Child Health 39(8), 635-636 (2003); see comment.
11. Panda NK, Sreedharan S, Mann SB, Sharma SC. Prognostic factors in complicated and uncomplicated chronic otitis media. Am. J. Otolaryngol. 17(6), 391-396 (1996).
12. Chu EA, Jackler RK, Chu EA, Jackler RK. The artificial tympanic membrane (1840-1910): from brilliant innovation to quack device. Otol. Neurotol. 24(3), 507-518 (2003). Interesting study examining the repair of tympanic membranes over centuries (prior to surgery) and the evolution of operative repair.
13. Ringenberg JC. Closure of tympanic membrane perforations by the use of fat. Laryngoscope 88(6), 982-993 (1978).
14. Aggarwal R, Saeed SR, Green KJ, Green KJM. Myringoplasty. J. Laryngol. Otol. 120(6), 429-432 (2006). Excellent clinical review of myringoplasty, with particular reference to prognostic factors.
15. Inwood JL, Wallace HC, Clarke SE. Endaural or postaural incision for myringoplasty: does it make a difference to the patient? Clin. Otolaryngol. Allied Sci. 28(5), 396-398 (2003); see comment.
16. Gerard JM, Gersdorff M. The Tutopatch graft for transcanal myringoplasty. B-ENT 2(4), 177-179 (2006).
17. Singh M, Rai A, Bandyopadhyay S et al. Comparative study of the underlay and overlay techniques of myringoplasty in large and subtotal perforations of the tympanic membrane. J. Laryngol. Otol. 117(6), 444-448 (2003).
18. Crovetto De La Torre M, Fiz Melsio L, Escobar Martinez A. [Myringoplasty in chronic simple otitis media. Comparative analysis of underlay and overlay techniques]. Acta Otorrinolaringologica Espanola 51(2), 101-104 (2000).
19. Vartiainen E, Nuutinen J. Success and pitfalls in myringoplasty: follow-up study of 404 cases. Am. J. Otol. 14(3), 301-305 (1993). Large retrospective study examining factors thought to influence the success of myringoplasty.
20. Kartush JM, Michaelides EM, Becvarovski Z et al. Over-under tympanoplasty. Laryngoscope 112(5), 802-807 (2002).
21. Eavey RD. Inlay tympanoplasty: cartilage butterfly technique. Laryngoscope 108(5), 657-661 (1998).
22. Ghanem MA, Monroy A, Alizade FS et al. Butterfly cartilage graft inlay tympanoplasty for large perforations. Laryngoscope 116(10), 1813-1816 (2006).
23. Effat KG, Effat KG. Results of inlay cartilage myringoplasty in terms of closure of central tympanic membrane perforations. J. Laryngol. Otol. 119(8), 611-613 (2005).
24. Schulte DL, Driscoll CL, McDonald TJ, Facer GW, Beatty CW. Irradiated rib cartilage graft for reconstruction of the tympanic membrane: preliminary results. Am. J. Otol. 19(2), 141-144 (1998).
25. Huttenbrink K. Current Topics in Otolaryngology - Head and Neck Surgery. Middle Ear Surgery - Recent Advances and Future Directions. Jahnke K (Ed.). Georg Thieme Verlag Publishers, Stuttgart, Germany (2004).
26. Vorwerk U, Hey M, Steinicke G, Begall K. High-speed digital videoimaging of fast eardrum motions during Valsalva maneuver. ORL J. Otorhinolaryngol. Relat. Spec. 60(3), 138-142 (1998).
27. Gerber MJ, Mason JC, Lambert PR. Hearing results after primary cartilage tympanoplasty. Laryngoscope 110(12), 1994-1999 (2000).
28. Dirckx JJ, Decraemer WF, von Unge M, Larsson C. Volume displacement of the gerbil eardrum pars flaccida as a function of middle ear pressure. Hearing Res. 118(1-2), 35-46 (1998).
29. Nagai T, Tono T. Encapsulated nerve corpuscles in the human tympanic membrane. Arch. Oto-Rhino-Laryngol. 246(3), 169-172 (1989).
30. Teoh SW, Flandermeyer DT, Rosowski JJ. Effects of pars flaccida on sound conduction in ears of Mongolian gerbil: acoustic and anatomical measurements. Hearing Res. 106(1-2), 39-65 (1997).
31. Karela M, Berry S, Watkins A, Phillipps JJ, Berry S. Myringoplasty: surgical outcomes and hearing improvement: is it worth performing to improve hearing? Probl. Actuels Otorhinolaryngol. 265(9), 1039-1042 (2008).
32. Dornhoffer JL, Dornhoffer JL. Cartilage tympanoplasty. Otolaryngol. Clin. N. Am. 39(6), 1161-1176 (2006).
33. Tos M, Tos M. Cartilage tympanoplasty methods: proposal of a classification. Otolaryngol. Head Neck Surg. 139(6), 747-758 (2008).
34. Yung M. Cartilage tympanoplasty: literature review. J. Laryngol. Otol. 122(7), 663-672 (2008).
35. Dursun E, Dogru S, Gungor A et al. Comparison of paper-patch, fat, and perichondrium myringoplasty in repair of small tympanic membrane perforations. Otolaryngol. Head Neck Surg. 138(3), 353-356 (2008).
36. Gierek T, Slaska-Kaspera A, Majzel K et al. [Results of myringoplasty and type I tympanoplasty with the use of fascia, cartilage and perichondrium grafts]. Otolaryngol. Polska 58(3), 529-533 (2004).
37. Williamson PA, Thomas DM, Beasley P. Posterior tragal perichondrium harvesting for myringoplasty. Clin. Otolaryngol. Allied Sci. 24(4), 252-254 (1999).
38. Fiorino F, Barbieri F. Fat graft myringoplasty after unsuccessful tympanic membrane repair. Eur. Arch. Oto-Rhino-Laryngol. 264(10), 1125-1128 (2007).
39. Landsberg R, Fishman G, DeRowe A et al. Fat graft myringoplasty: results of a long-term follow-up. J. Otolaryngol. 35(1), 44-47 (2006).
40. Ozgursoy OB, Yorulmaz I. Fat graft myringoplasty: a cost-effective but underused procedure. J. Laryngol. Otol. 119(4), 277-279 (2005).
41. Golz A, Goldenberg D, Netzer A et al. Paper patching for chronic tympanic membrane perforations. Otolaryngol. Head Neck Surg. 128(4), 565-570 (2003).
42. Saadat D, Ng M, Vadapalli S, Sinha UK. Office myringoplasty with alloderm. Laryngoscope 111(1), 181-184 (2001).
43. Youssef AM. Use of acellular human dermal allograft in tympanoplasty. Laryngoscope 109(11), 1832-1833 (1999).
44. Mansour MH, Askar MH, Albirmawy OA. Repair of tympanic membrane perforation using a modified cartilage-perichondrium composite ring graft. J. Laryngol. Otol. 120(11), 952-954 (2006).
45. Dornhoffer J, Dornhoffer J. Cartilage tympanoplasty: indications, techniques, and outcomes in a 1,000-patient series. Laryngoscope 113(11), 1844-1856 (2003).
46. Puls T. Tympanoplasty using conchal cartilage graft. Acta Otorhinolaryngol. Belg. 57(3), 187-191 (2003).
47. El-Hennawi DM. Cartilage perichondrium composite graft (CPCG) in pediatric tympanoplasty. Int. J. Pediat. Otorhinolaryngol. 59(1), 1-5 (2001).
48. Vos JD, Latev MD, Labadie RF et al. Use of AlloDerm in type I tympanoplasty: a comparison with native tissue grafts. Laryngoscope 115(9), 1599-1602 (2005).
49. Yetiser S, Tosun F, Satar B. Revision myringoplasty with solvent-dehydrated human dura mater (Tutoplast). Otolaryngolo. Head Neck Surg. 124(5), 518-521 (2001).
50. Packer P, Mackendrick A, Solar M. What's best in myringoplasty: underly or overlay, dura or fascia? J. Laryngol. Otol. 96(1), 25-41 (1982).
51. Raghavan U, Malki DS, Mahmoud NA. Myringoplasty: update on onlay pedicle skin flap and temporalis fascia sandwich graft. J. Laryngol. Otol. 114(3), 174-177 (2000).
52. Henein RR, Gandhi AG. Myringoplasty using free tragal cartilage and pedicled meatal skin flap. J. Laryngol. Otol. 94(9), 1005-1008 (1980).
53. Chanvimalueng W. A clinical comparison of outpatient and standard myringoplasty. Ear Nose Throat J. 79(2), 113-114 (2000).
54. Park AH, Hughes CW, Jackson A et al. Crosslinked hydrogels for tympanic membrane repair. Otolaryngol. Head Neck Surg. 135(6), 877-883 (2006).
55. Spiegel JH, Kessler JL, Spiegel JH, Kessler JL. Tympanic membrane perforation repair with acellular porcine submucosa. Otol. Neurotol. 26(4), 563-566 (2005).
56. Strasser GM, Schratzenstaller B. [Myringoplasty with autologous mucosagraft]. Laryngorhinootologie 87(2), 93-95 (2008).
57. Ajulo SO, Myatt HM, Alusi G. Peri-umbilical superficial fascial graft myringoplasty - a simple alternative. Clin. Otolaryngol. Allied Sci. 18(5), 433-435 (1993).
58. Miyoshi T, Watanabe T, Yokose H, Okitsu T. [Myringoplasty by means of a vein graft]. Jibiinkoka 43(1), 25-30 (1971).
59. Jelinek R, Herodek F. [Myringoplasty using a venous graft according the Shea]. Ceskoslovenska Otolaryngol. 16(6), 362-364 (1967).
60. Valenzuela C. Myringoplasty. Experience with vein graft technics. Int. Surg. 47(1), 87-96 (1967).
61. Richards SH, McGee TM. Experimental observations on vein graft myringoplasty. J. Laryngol. Otol. 79(11), 952-963 (1965).
62. Mitchell JF. Myringoplasty by homogenous vein graft. J. Laryngol. Otol. 81(3), 339-346 (1967).
63. Heck WE. Vein graft myringoplasty. Laryngoscope 71, 847-853 (1961).
64. Lyons GD, Dyer RF, Ruby JR. Morphologic analysis of tympanic membrane grafts. Laryngoscope 87(10 Pt 1), 1705-1709 (1977).
65. Cornish CB, Scott PJ. Freeze dried heart valves as tympanic grafts. Arch. Otolaryngol. 88(4), 350-356 (1968).
66. Moy RL, Lee A, Zalka A. Commonly used suture materials in skin surgery. Am. Fam. Physician 44(6), 2123-2128 (1991).
67. Schmutz F, McAuliffe W, Anderson DM, Elliott JP, Eskridge JM, Winn HR. Embolization of cerebral arteriovenous malformations with silk: histopathologic changes and hemorrhagic complications. Am. J. Neuroradiol. 18(7), 1233-1237 (1997).
68. Song JK, Eskridge JM, Chung EC et al. Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J. Neurosurg. 92(6), 955-960 (2000).
69. Dehdashti AR, Muster M, Reverdin A, de Tribolet N, Ruefenacht DA. Preoperative silk suture embolization of cerebral and dural arteriovenous malformations. Neurosurg. Focus 11(5), E6 (2001).
70. Salthouse TN. Biologic response to sutures. Otolaryngol. Head Neck Surg. 88(6), 658-664 (1980).
71. Wang Y, Kim HJ, Vunjak-Novakovic G et al. Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27(36), 6064-6082 (2006). Superb review of stem cell-based tissue engineering and the application of silk fibroin to this arena. Future directions and uses of silk biomaterials are discussed.
72. Liu H, Ge Z, Wang Y et al. Modification of sericin-free silk fibers for ligament tissue engineering application. J. Biomed. Mater. Res. Part B Appl. Biomater. 82(1), 129-138 (2007).
73. Yamada H, Igarashi Y, Takasu Y et al. Identification of fibroin-derived peptides enhancing the proliferation of cultured human skin fibroblasts. Biomaterials 25(3), 467-472 (2004).
74. Unger RE, Peters K, Wolf M, Motta A, Migliaresi C, Kirkpatrick CJ. Endothelialization of a non-woven silk fibroin net for use in tissue engineering: growth and gene regulation of human endothelial cells. Biomaterials 25(21), 5137-5146 (2004).
75. Gotoh Y, Niimi S, Hayakawa T et al. Preparation of lactose-silk fibroin conjugates and their application as a scaffold for hepatocyte attachment. Biomaterials 25(6), 1131-1140 (2004).
76. Santin M, Motta A, Freddi G, Cannas M. In vitro evaluation of the inflammatory potential of the silk fibroin. J. Biomed. Mater. Res. 46(3), 382-389 (1999).
77. Kim KH, Jeong L, Park HN et al. Biological efficacy of silk fibroin nanofiber membranes for guided bone regeneration. J. Biotechnol. 120(3), 327-339 (2005).
78. Minoura N, Tsukada M, Nagura M. Physico-chemical properties of silk fibroin membrane as a biomaterial. Biomaterials 11(6), 430-434 (1990).
79. Altman GH, Diaz F, Jakuba C et al. Silk-based biomaterials. Biomaterials 24(3), 401-416 (2003). Excellent review of silk biomaterials from silk worms and spiders. Discusses properties of silk, biomedical utility, biocompatibility and degradation.
80. Gellynck K, Verdonk P, Forsyth R et al. Biocompatibility and biodegradability of spider egg sac silk. J. Mater. Sci. Mater. Med. 19(8), 2963-2970 (2008).
81. Yang Y, Chen X, Ding F et al. Biocompatibility evaluation of silk fibroin with peripheral nerve tissues and cells in vitro. Biomaterials 28(9), 1643-1652 (2007).
82. Mei N, Zhou P, Pan LF et al. Biocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) modified by silk fibroin. J. Mater. Sci. Mater. Med. 17(8), 749-758 (2006).
83. Ma X, Cao C, Zhu H, Ma X, Cao C, Zhu H. The biocompatibility of silk fibroin films containing sulfonated silk fibroin. J. Biomed. Mater. Res. Part B Appl. Biomater. 78(1), 89-96 (2006).
84. Jiang Y, Chen H, Zhou W et al. [Research on preparation of silk fibroin and its biocompatibility with rat bone marrow mesenchymal stem cells]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 23(3), 560-564 (2006).
85. Acharya C, Ghosh SK, Kundu SC. Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion. J. Mater. Sci. Mater. Med. 19(8), 2827-2836 (2008).
86. Uragoda CG, Wijekoon PN. Asthma in silk workers. J. Soc. Occupation. Med. 41(3), 140-142 (1991).
87. Vovolis V, Galatas I. Silk-induced asthma. Allergy Asthma Proc. 20(2), 107-108 (1999).
88. Wen CM, Ye ST, Zhou LX, Yu Y. Silk-induced asthma in children: a report of 64 cases. Ann. Allergy 65(5), 375-378 (1990).
89. Zaoming W, Codina R, Fernandez-Caldas E, Lockey RF. Partial characterization of the silk allergens in mulberry silk extract. J. Invest. Allergol. Clin. Immunol. 6(4), 237-241 (1996).
90. Meinel L, Hofmann S, Karageorgiou V et al. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol. Bioeng. 88(3), 379-391 (2004).
91. Li C, Vepari C, Jin HJ et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27(16), 3115-3124 (2006).
92. Allmeling C, Jokuszies A, Reimers K et al. Use of spider silk fibres as an innovative material in a biocompatible artificial nerve conduit. J. Cell. Mol. Med. 10(3), 770-777 (2006).
93. Tang X, Ding F, Yang Y, Hu N, Wu H, Gu X. Evaluation on in vitro biocompatibility of silk fibroin-based biomaterials with primarily cultured hippocampal neurons. J. Biomed. Mater. Res. A. 91(1), 166-174. (2009).
94. Chirila T, Barnard Z, Zainuddin Z et al. Bombyx mori silk fibroin membranes as potential substrata for epithelial constructs used in the management of ocular surface disorders. Tissue engineering Part A 14(7), 1203-1211 (2008).
95. Marolt D, Augst A, Freed LE et al. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials 27(36), 6138-6149 (2006).
96. Wang Y, Blasioli DJ, Kim HJ et al. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 27(25), 4434-4442 (2006).
97. Meinel L, Karageorgiou V, Hofmann S et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J. Biomed. Mater. Res. A 71(1), 25-34 (2004).
98. Acharya C, Ghosh SK, Kundu SC, Acharya C, Ghosh SK. Silk fibroin film from non-mulberry tropical tasar silkworms: a novel substrate for in vitro fibroblast culture. Acta Biomaterialia 5(1), 429-437 (2009).
99. Meinel L, Hofmann S, Karageorgiou V et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 26(2), 147-155 (2005).
100. Unger RE, Wolf M, Peters K et al. Growth of human cells on a non-woven silk fibroin net: a potential for use in tissue engineering. Biomaterials 25(6), 1069-1075 (2004).
101. Cirillo B, Morra M, Catapano G. Adhesion and function of rat liver cells adherent to silk fibroin/collagen blend films. Int. J. Artif. Organs 27(1), 60-68 (2004).
102. Uebersax L, Fedele DE, Schumacher C et al. The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials 27(26), 4599-4607 (2006).
103. Bayraktar O, Malay O, Ozgarip Y et al. Silk fibroin as a novel coating material for controlled release of theophylline. Eur. J. Pharma. Biopharma. 60(3), 373-381 (2005).
104. Dal Pra I, Freddi G, Minic J et al. De novo engineering of reticular connective tissue in vivo by silk fibroin nonwoven materials. Biomaterials 26(14), 1987-1999 (2005).
105. Meinel L, Betz O, Fajardo R et al. Silk based biomaterials to heal critical sized femur defects. Bone 39(4), 922-931 (2006); erratum: 43(6), 1123 (2008).
106. Fan H, Liu H, Wong EJ et al. In vivo study of anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold. Biomaterials 29(23), 3324-3337 (2008).
107. Yang Y, Ding F, Wu J et al. Development and evaluation of silk fibroin-based nerve grafts used for peripheral nerve regeneration. Biomaterials 28(36), 5526-5535 (2007).
108. Ni Y, Zhao X, Zhou L et al. Radiologic and histologic characterization of silk fibroin as scaffold coating for rabbit tracheal defect repair. Otolaryngol. Head Neck Surg. 139(2), 256-261 (2008).
109. Park KE, Jung SY, Lee SJ et al. Biomimetic nanofibrous scaffolds: preparation and characterization of chitin/silk fibroin blend nanofibers. Int. J. Biolog. Macromol. 38(3-5), 165-173 (2006).
110. Min BM, Lee G, Kim SH et al. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 25(7-8), 1289-1297 (2004).
111. Min BM, Jeong L, Nam YS et al. Formation of silk fibroin matrices with different texture and its cellular response to normal human keratinocytes. Int. J. Biolog. Macromol. 34(5), 281-288 (2004).
112. Levin B, Redmond SL, Rajkhowa R et al. Preliminary results of the application of a silk fibroin scaffold to otology. Otolaryngol. Head Neck Surg. DOI:10.1016/j. otohns.2009.06.746 (2009) (Epub ahead of print).
113. Ghassemifar R, Redmond SL, Zainuddin Z et al. Advancing towards a tissueengineered tympanic membrane: silk fibroin as a substratum for growing human eardrum keratinocytes. J. Biomater. Appl. DOI: 10.1177/ 0885328209104289 (2009) (Epub ahead of print).
114. Kweon H, Yeo JH, Lee KG et al. Semiinterpenetrating polymer networks composed of silk fibroin and poly(ethylene glycol) for wound dressing. Biomed. Mater. 3(3), 034115 (2008).
115. Roh DH, Kang SY, Kim JY et al. Wound healing effect of silk fibroin/alginateblended sponge in full thickness skin defect of rat. J. Mater. Sci. Mater. Med. 17(6), 547-552 (2006).
116. Sugihara A, Sugiura K, Morita H et al. Promotive effects of a silk film on epidermal recovery from full-thickness skin wounds. Proc. Soc. Exp. Biol. Med. 225(1), 58-64 (2000).
117. Wang Y, Rudym DD, Walsh A et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 29(24-25), 3415-3428 (2008). Studies in vivo degradation of silk fibroin and examines the various factors that influence this process, discussing how these can be manipulated for clinical purposes.
118. Kim UJ, Park J, Kim HJ et al. Threedimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26(15), 2775-2785 (2005).
119. Horan RL, Antle K, Collette AL et al. In vitro degradation of silk fibroin. Biomaterials 26(17), 3385-3393 (2005).
120. WHO. Chronic Suppurative Otitis Media. Burden of Illness and Management Options (2004) www.who.int/pbd/deafness/activities/ hearing-care/otitis-media. pdf
121. WHO. Global Burden of Hearing Loss in the Year 2000 www.who.int/ healthinfo/statistics/bod- hearingloss.pdf